From: Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer
HR
95%CI
P
Lower
Upper
Rad score
0.005
4.572*10–3
0.043
< 0.001
CRP
1.015
0.996
1.035
0.130
M stage
2.449
1.138
5.269
0.020